Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01073410 · ClinicalTrials.gov registry record
Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 23
- Enrollment target
NCT01073410 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 23 participants.
The verdict
NCT01073410 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the roles of two specific gene families (the chitinase gene family and the TGFB family). We hypothesize that chitinases and TGFb pathway genes will be differentially expressed in the airways of non-asthmatic subjects and subjects with asthma. We further hypothesize that genetic variants in CHIT1, AMCase, and TGFb pathway genes that show associations with asthma and related phenotypes will change the expression and/or function of the protein of these genes in the airway in several ways, including the transcript numbers for full length genes and splice variants and, for the chitinase genes, the levels of chitinase activity in airway secretions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-02 |
| Est. Completion | 2021-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01073410
The ClinicalTrials.gov registry entry for NCT01073410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01073410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01073410 about?
NCT01073410 is a clinical study titled "Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma". The purpose of this study is to find out the roles of two specific gene families (the chitinase gene family and the TGFB family). We hypothesize that chitinases and TGFb pathway genes will be differentially expressed in the airways of non-asthmatic subjects and subjects with asthma. We further hypot...
What is the current status of trial NCT01073410?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2010-02. Estimated completion is 2021-04.
Who is sponsoring clinical trial NCT01073410?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.